These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22486368)

  • 21. Conserved core substructures in the overlay of protein-ligand complexes.
    Finzel BC; Akavaram R; Ragipindi A; Van Voorst JR; Cahn M; Davis ME; Pokross ME; Sheriff S; Baldwin ET
    J Chem Inf Model; 2011 Aug; 51(8):1931-41. PubMed ID: 21736376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coverage and bias in chemical library design.
    Gregori-Puigjané E; Mestres J
    Curr Opin Chem Biol; 2008 Jun; 12(3):359-65. PubMed ID: 18423416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How well can fragments explore accessed chemical space? A case study from heat shock protein 90.
    Roughley SD; Hubbard RE
    J Med Chem; 2011 Jun; 54(12):3989-4005. PubMed ID: 21561141
    [No Abstract]   [Full Text] [Related]  

  • 24. Exploring the chemogenomic knowledge space with annotated chemical libraries.
    Savchuk NP; Balakin KV; Tkachenko SE
    Curr Opin Chem Biol; 2004 Aug; 8(4):412-7. PubMed ID: 15288252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relating protein pharmacology by ligand chemistry.
    Keiser MJ; Roth BL; Armbruster BN; Ernsberger P; Irwin JJ; Shoichet BK
    Nat Biotechnol; 2007 Feb; 25(2):197-206. PubMed ID: 17287757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands.
    Weill N; Rognan D
    J Chem Inf Model; 2009 Apr; 49(4):1049-62. PubMed ID: 19301874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global mapping of pharmacological space.
    Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL
    Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biology-oriented synthesis.
    Wetzel S; Bon RS; Kumar K; Waldmann H
    Angew Chem Int Ed Engl; 2011 Nov; 50(46):10800-26. PubMed ID: 22038946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge-based chemoinformatic approaches to drug discovery.
    Ghose AK; Herbertz T; Salvino JM; Mallamo JP
    Drug Discov Today; 2006 Dec; 11(23-24):1107-14. PubMed ID: 17129830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ChemGPS-NP: tuned for navigation in biologically relevant chemical space.
    Larsson J; Gottfries J; Muresan S; Backlund A
    J Nat Prod; 2007 May; 70(5):789-94. PubMed ID: 17439280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What we have learned from crystal structures of proteins to receptor function.
    Reymond JL; van Deursen R; Bertrand D
    Biochem Pharmacol; 2011 Dec; 82(11):1521-7. PubMed ID: 21787757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel multilevel statistical method for the study of the relationships between multireceptorial binding affinity profiles and in vivo endpoints.
    Selent J; Bauer-Mehren A; López L; Loza MI; Sanz F; Pastor M
    Mol Pharmacol; 2010 Feb; 77(2):149-58. PubMed ID: 19903829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the bioactivity-relevant chemical space of robust reactions and common molecular building blocks.
    Hartenfeller M; Eberle M; Meier P; Nieto-Oberhuber C; Altmann KH; Schneider G; Jacoby E; Renner S
    J Chem Inf Model; 2012 May; 52(5):1167-78. PubMed ID: 22512717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC; Reymond JL
    J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based development of target-specific compound libraries.
    Orry AJ; Abagyan RA; Cavasotto CN
    Drug Discov Today; 2006 Mar; 11(5-6):261-6. PubMed ID: 16580603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLIDA: GPCR--ligand database for chemical genomics drug discovery--database and tools update.
    Okuno Y; Tamon A; Yabuuchi H; Niijima S; Minowa Y; Tonomura K; Kunimoto R; Feng C
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D907-12. PubMed ID: 17986454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.